180 related articles for article (PubMed ID: 28833765)
1. Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation.
Coyle K; Coyle D; Lester-George A; West R; Nemeth B; Hiligsmann M; Trapero-Bertran M; Leidl R; Pokhrel S;
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):7-18. PubMed ID: 28833765
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.
Trapero-Bertran M; Muñoz C; Coyle K; Coyle D; Lester-George A; Leidl R; Németh B; Cheung KL; Pokhrel S; Lopez-Nicolás Á
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):65-75. PubMed ID: 29532966
[TBL] [Abstract][Full Text] [Related]
3. Estimates of costs for modelling return on investment from smoking cessation interventions.
Trapero-Bertran M; Leidl R; Muñoz C; Kulchaitanaroaj P; Coyle K; Präger M; Józwiak-Hagymásy J; Cheung KL; Hiligsmann M; Pokhrel S;
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):32-41. PubMed ID: 29532538
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD.
Anraad C; Cheung KL; Hiligsmann M; Coyle K; Coyle D; Owen L; West R; de Vries H; Evers SM; Pokhrel S
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):96-105. PubMed ID: 29430762
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD.
Huber MB; Präger M; Coyle K; Coyle D; Lester-George A; Trapero-Bertran M; Nemeth B; Cheung KL; Stark R; Vogl M; Pokhrel S; Leidl R
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):52-64. PubMed ID: 29243347
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD.
Németh B; Józwiak-Hagymásy J; Kovács G; Kovács A; Demjén T; Huber MB; Cheung KL; Coyle K; Lester-George A; Pokhrel S; Vokó Z
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):76-86. PubMed ID: 29368363
[TBL] [Abstract][Full Text] [Related]
7. Is it cost-effective to provide internet-based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD.
Cheung KL; Wijnen BFM; Hiligsmann M; Coyle K; Coyle D; Pokhrel S; de Vries H; Präger M; Evers SMAA
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):87-95. PubMed ID: 29243351
[TBL] [Abstract][Full Text] [Related]
8. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
[TBL] [Abstract][Full Text] [Related]
9. A utility of model input uncertainty analysis in transferring tobacco control-related economic evidence to countries with scarce resources: results from the EQUIPT study.
Németh B; Kulchaitanaroaj P; Lester-George A; Huic M; Coyle K; Coyle D; Pokhrel S; Kaló Z
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):42-51. PubMed ID: 29377316
[TBL] [Abstract][Full Text] [Related]
10. Estimates of effectiveness and reach for 'return on investment' modelling of smoking cessation interventions using data from England.
West R; Coyle K; Owen L; Coyle D; Pokhrel S;
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):19-31. PubMed ID: 28833834
[TBL] [Abstract][Full Text] [Related]
11. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
12. EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control.
Pokhrel S; Evers S; Leidl R; Trapero-Bertran M; Kalo Z; Vries Hd; Crossfield A; Andrews F; Rutter A; Coyle K; Lester-George A; West R; Owen L; Jones T; Vogl M; Radu-Loghin C; Voko Z; Huic M; Coyle D
BMJ Open; 2014 Nov; 4(11):e006945. PubMed ID: 25421342
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
[TBL] [Abstract][Full Text] [Related]
14. Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework.
Connolly MP; Baker CL; Kotsopoulos N
J Med Econ; 2018 Jun; 21(6):571-576. PubMed ID: 29376747
[TBL] [Abstract][Full Text] [Related]
15. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
Bertram MY; Lim SS; Wallace AL; Vos T
Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
[TBL] [Abstract][Full Text] [Related]
16. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
O'Donnell MP; Roizen MF
Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
[TBL] [Abstract][Full Text] [Related]
17. Healthcare financing systems for increasing the use of tobacco dependence treatment.
van den Brand FA; Nagelhout GE; Reda AA; Winkens B; Evers SMAA; Kotz D; van Schayck OC
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004305. PubMed ID: 28898403
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of a Health System-Based Smoking Cessation Program.
Levy DE; Klinger EV; Linder JA; Fleegler EW; Rigotti NA; Park ER; Haas JS
Nicotine Tob Res; 2017 Nov; 19(12):1508-1515. PubMed ID: 27639095
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
[TBL] [Abstract][Full Text] [Related]
20. Cost-benefit analysis of funding smoking cessation before surgery.
Jiménez-Ruiz CA; Martín V; Alsina-Restoy X; de Granda-Orive JI; de Higes-Martínez E; García-Rueda M; Genovés-Crespo M; López-García C; Lorza-Blasco JJ; Márquez FL; Ramos-Pinedo Á; Riesco-Miranda JA; Signes-Costa J; Solano-Reina S; Vaquero-Lozano P; Rejas J
Br J Surg; 2020 Jul; 107(8):978-994. PubMed ID: 32372474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
